Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11794 | Berzosertib | 1 | Active Not Recruiting | 1 |
DB00002 | Cetuximab | 1 | Completed | 1 |
DB14547 | Chloride ion | 1 | Active Not Recruiting | 2 |
DB00515 | Cisplatin | 1 | Active Not Recruiting | 2 |
DB00515 | Cisplatin | 1 | Completed | 1 |
DB06186 | Ipilimumab | 1 | Completed | 1 |
DB06306 | Onalespib | 1 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Completed | 1 |
DB12257 | Platinum | 1 | Active Not Recruiting | 2 |
DB11595 | Atezolizumab | 2 / 3 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 / 3 | Suspended | 1 |
DB00002 | Cetuximab | 2 / 3 | Recruiting | 1 |
DB00002 | Cetuximab | 2 / 3 | Suspended | 1 |
DB14547 | Chloride ion | 2 / 3 | Recruiting | 1 |
DB14547 | Chloride ion | 2 / 3 | Suspended | 1 |
DB00515 | Cisplatin | 2 / 3 | Recruiting | 1 |
DB00515 | Cisplatin | 2 / 3 | Suspended | 1 |
DB01248 | Docetaxel | 2 / 3 | Recruiting | 1 |
DB01248 | Docetaxel | 2 / 3 | Suspended | 1 |
DB12257 | Platinum | 2 / 3 | Recruiting | 1 |
DB12257 | Platinum | 2 / 3 | Suspended | 1 |